Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Titel:
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial
Auteur:
Vijiaratnam, Nirosen Girges, Christine Auld, Grace McComish, Rachel King, Alexa Skene, Simon S Hibbert, Steve Wong, Alan Melander, Sabina Gibson, Rachel Matthews, Helen Dickson, John Carroll, Camille Patrick, Abigail Inches, Jemma Silverdale, Monty Blackledge, Bethan Whiston, Jessica Hu, Michele Welch, Jessica Duncan, Gordon Power, Katie Gallen, Sarah Kerr, Jacqueline Chaudhuri, K Ray Batzu, Lucia Rota, Silvia Jabbari, Edwin Morris, Huw Limousin, Patricia Greig, Nigel Li, Yazhou Libri, Vincenzo Gandhi, Sonia Athauda, Dilan Chowdhury, Kashfia Foltynie, Tom